Beyond dentistry: KYomed INNOV develops ePRO a digital health information reporting device
Dental Review reports the news of an interesting digital health information collection and reporting device from across the Channel.
Kyomed, a French company offering services in connected healthcare, autonomy and personalised medicine, today (19th June) marks its fourth anniversary by announcing its name change to KYomed INNOV. The company will also be developing its own range of digital tools and upping its involvement in international projects.
Its first proprietary digital tool is its ePRO (electronic Patient Reported Outcomes). This application allows patients – in the context of biomedical research – to self-report on their symptoms, state of health and on the impact of medical interventions on their daily life. Medical information can be reported while the patient is in their everyday environment or on an outpatient basis.
A spokesperson for KYomed INNOV explained: “Unlike other available applications, ePRO is fully customisable for investigators while also remaining intuitive and very easy to use for patients.
“This application answers new recommendations from the French regulatory health authorities. In October 2016, the French health authority HAS (Haute Autorité de Santé) published a good practice guide (section 2.7) for connected health applications and devices which recommends gathering data about the way patients feel both at a clinical centre and in their everyday environment.
“Thanks to this tool our clients will be able to integrate all of this data into their clinical studies and strengthen their applications with a view to achieving a CE and/or FDA mark. Pilot studies will run into the third quarter of 2018.
“Feedback from healthcare professionals and patients will be taken into account when making any improvements, if required. The ePRO will be available from November 2018, initially in French and English before being rolled out in other languages.”
Daniel Laune, president of KYomed INNOV, stated: "To mark our company's fourth birthday, we are making a fresh start with a new name and our first digital tool. Today, we are reinventing ourselves, using our expertise to launch global projects and to develop innovative solutions which offer a real benefit to our clients while putting people at the forefront of the initiative."
The company also plans to support its expansion into the international market by participating in various conferences: Digital Biomarkers in Clinical Trials (June 20, 2018, Basel, Switzerland), MedFIT (June 26-27, 2018, Strasbourg, France) and PCT (November 27-29, 2018, Barcelona, Spain).
KYomed INNOV already participates in important international projects, such as the European project POLLAR (Impact of Pollution on Asthma and Rhinitis), which last year was awarded €2M ($2.3M) by EIT Health in the “Innovation by Design” category.
The project aims to define the link between pollution, pollen and respiratory conditions. The data is collected via an application (Allergy Diary), the development of which is being coordinated by KYomed INNOV.